SCHEMBL6930495

SCHEMBL6930495

CC1(C)CCCC2=C1Cc1ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 1/20 0.44
▸ HTR1A P08908 1/20 0.44
▸ ADRA2A P08913 1/20 0.44
▸ CHRM1 P11229 1/20 0.44
▸ DRD1 P21728 1/20 0.44
▸ SLC6A2 P23975 1/20 0.44
▸ SLC6A4 P31645 1/20 0.44
▸ ADRA1A P35348 1/20 0.44
▸ OPRM1 P35372 1/20 0.44
▸ DRD3 P35462 1/20 0.44
▸ SLC6A3 Q01959 1/20 0.44
▸ KCNH2 Q12809 1/20 0.44
▸ KDM1A O60341 1/20 0.40
▸ MCL1 Q07820 1/20 0.35
▸ MAOA P21397 2/20 0.35
▸ IDO1 P14902 2/20 0.35
▸ ACHE P22303 1/20 0.35
▸ TDP2 O95551 2/20 0.34
▸ CASP3 P42574 1/20 0.34
▸ CASP7 P55210 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30267096 0.77 KDM1A (0.34) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL8893531 0.76 DRD1 (0.45) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL202264 0.71 TSHR (0.44) CHRM2HTR1AADRA2ACHRM1DRD1
Methane SCHEMBL5909544 0.69 SIGMAR1 (0.43) CHRM2HTR1AADRA2ACHRM1DRD1
Lithium SCHEMBL7545662 0.69 SIGMAR1 (0.43) CHRM2HTR1AADRA2ACHRM1DRD1
Potassium SCHEMBL7551769 0.69 SIGMAR1 (0.43) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL11772501 0.68 ADRA2A (0.38) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL11772425 0.67 CHRM2 (0.37) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL11772497 0.67 HTR2A (0.38) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL11771917 0.67 CHRM2 (0.37) CHRM2HTR1AADRA2ACHRM1DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107000124-A Method for manufacturing optical film 日本瑞翁株式会社 2017-08-01 — — CN disclosed
EP-1120389-B1 Preparation process of fluorenes JFE CHEMICAL CORP (JP) 2003-11-26 — — EP disclosed
US-6344585-B2 DEHYDROGENATION OF THE CORRESPONDING TETRAHYDROFLUORENECOMPOUND ADCHEMCO CORPORATION (JP) 2002-02-05 — — US disclosed
US-20010011144-A1 Preparation process of fluorenes ADCHEMCO CORPORATION (JP) 2001-08-02 — — US disclosed
EP-1120389-A1 Preparation process of fluorenes Adchemco Corporation (JP) 2001-08-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010011144-A1 Preparation process of fluorenes AFF1, NAF1, RER1 CHRM2 2866/4885HTR1A 270/4885ADRA2A 1998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback